Research Article
Phase I Study of the Novel Antifungal Agent Dapaconazole (Zilt®) in Healthy Volunteers

Citation to this article as recorded by ASCI
Gobbato, A.A.M., T. Babadopulos, C.A.R.S. Gobbato, J.D.O. Ilha, T. Gagliano-Juca and G. De Nucci, 2015. A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor. Expert Opin. Investig. Drugs., 24: 1399-1407.
CrossRef  |  PubMed  |  Direct Link  |  

Services
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

 
©  2020 Science Alert. All Rights Reserved